SINGAPORE NATIONAL EYE CENTRE
πΈπ¬Singapore
- Country
- πΈπ¬Singapore
- Ownership
- -
- Established
- 1990-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.snec.com.sg/
Clinical Trials
78
Active:2
Completed:57
Trial Phases
6 Phases
Early Phase 1:3
Phase 1:5
Phase 2:3
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (54 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
32 (59.3%)Phase 3
6 (11.1%)Phase 1
5 (9.3%)Phase 4
5 (9.3%)Early Phase 1
3 (5.6%)Phase 2
3 (5.6%)International Multi-centre, Prospective, Longitudinal Cohort to Evaluate the Progression Pattern of Choroidal Venous Alterations
Recruiting
- Conditions
- Pachychoroid Disease
- First Posted Date
- 2025-11-19
- Last Posted Date
- 2025-11-19
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 250
- Registration Number
- NCT07236671
- Locations
- ππ°
Hong Kong University, Hong Kong, Hong Kong
π²πΎUniversity of Malaya Medical Centre, Kuala Lumpur, Malaysia
πΈπ¬National University Hospital, Singapore, Singapore, Singapore
Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore
Active, not recruiting
- Conditions
- UveitisScleritis and EpiscleritisEndophthalmitisIntraocular LymphomaMasquerade Syndromes
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-16
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 200
- Registration Number
- NCT07176130
- Locations
- πΈπ¬
Singapore National Eye Centre, Singapore, Singapore
Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study]
Phase 3
Not yet recruiting
- Conditions
- MyopiaStrabismus
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06863675
- Locations
- πΈπ¬
Singapore National Eye Centre, Singapore, Singapore
Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression
Phase 2
Not yet recruiting
- Conditions
- Myopia
- Interventions
- Drug: Atropine 0.025%Device: Single vision Contact lensDevice: Multizonal contact lensDrug: Placebo
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 180
- Registration Number
- NCT06765603
Evaluation of Performance of MiYOSMART Photochromic and Clear Spectacle Lenses in Myopic Children
Not Applicable
Not yet recruiting
- Conditions
- MyopiaMyopia Progression
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Singapore National Eye Centre
- Target Recruit Count
- 202
- Registration Number
- NCT06717035
- Locations
- πΈπ¬
Singapore National Eye Centre, Singapore, Singapore
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
Singapore AI Platform Cuts Clinical Audit Time by 90%, Partners with Roche for Clinical Trial Acceleration
Enigma Health's AI platform reduced clinical audit time from 528 hours to 7 hours during a pilot at Singapore National Eye Centre, analyzing over 7,000 cataract surgeries.